Illumina ILMN
NASDAQ ILMN
$227.74 +2.90 (+1.29%)
As of: Aug 27, 2026 · 3:59 PM EDT

Illumina (ILMN) Receivables - Other (2021 - 2026)

Illumina (ILMN) posted quarterly Receivables - Other of $16.0 million for Q1 2022, up 14.29% year-over-year from $14.0 million in Q1 2021, and up 14.29% on a QoQ basis from $14.0 million in Q1 2021.

Illumina (ILMN) Receivables - Other (2021 - 2026) Analysis & Trends

Illumina has reported Receivables - Other for 2 years, with the latest figure at $16.0 million in Q1 2022.

  • Receivables - Other for Q1 2022 came in at $16.0 million, up 14.29% year-over-year; the trailing twelve-month figure through Jan 2022 was $16.0 million (up 14.29% YoY), and the FY2022 annual result was $16.0 million, up 14.29% from the prior year.
  • Receivables - Other climbed to $16.0 million in Q1 2022, from $14.0 million in the prior quarter.
  • Over five years, Receivables - Other peaked at $16.0 million in Q1 2022 and troughed at $14.0 million in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn
10 Quest Diagnostics 27.10 Bn 26.47 Bn 1.03 Bn

Historic Data

Download Data
DateValue
Jun 28, 2026 18.00 Mn
Jun 28, 2026 18.00 Mn
Mar 29, 2026 3.00 Mn
Mar 29, 2026 3.00 Mn
Dec 28, 2025 8.00 Mn
Dec 28, 2025 8.00 Mn
Jan 2, 2022 16.00 Mn
Jan 2, 2022 16.00 Mn
Jan 3, 2021 14.00 Mn
Jan 3, 2021 14.00 Mn